Evaluation of the Greiner Bio-One serum separator BCA Fast Clot tube
-
Goce Dimeski
,
Julie Johnston
Abstract
Background:
Current commercial tubes have difficulties in producing “true” serum from all blood samples even within the recommended clotting times. Hence, Becton Dickinson (BD) and now Greiner have produced tubes containing thrombin as the procoagulant to reduce the clotting time and increase the possibility of producing serum from anticoagulated blood samples.
Methods:
The Greiner BCA Fast Clot (GBBCAFC) tube was evaluated in a hospital environment using 40 participants, (30 healthy and 10 undergoing renal dialysis) for 32 analytes against the Greiner lithium heparin tube and the BD Rapid Serum Tubes (BD RST) tube measured on Beckman DxC 800 and DxI 800 analyzers. Clotting strength was also examined using thromboelastography (TEG).
Results:
The analytes results showed there was a very close agreement between the BD RST tube and GBBCAFC tube in comparison with lithium heparin plasma. The result comparison data showed equivalent performance with lower levels of hemolysis. The prolonged storage study also showed very similar agreement between the BD RST and the GBBCAFC tubes. Likewise, the TEG data showed there was very little difference in clotting ability between the tubes, and neither was capable of producing true serum from blood spiked with 2 U heparin/mL of blood.
Conclusions:
The study showed the GBBCAFC tube with the combination of the two procoagulants blood clotting activator and thrombin produced comparable performance with the lithium heparin plasma and the BD RST serum samples.
Author contributions: All the authors have accepted responsibility for the entire content of this submitted manuscript and approved submission.
Research funding: The study was largely funded by Greiner Bio-One.
Employment or leadership: None declared.
Honorarium: None declared.
Competing interests: The funding organization(s) played no role in the study design; in the collection, analysis, and interpretation of data; in the writing of the report; or in the decision to submit the report for publication.
Appendix
Anticoagulation type and dosing of the renal dialysis patients at the time of the sample collection, and clotting related details of anticoagulated dialysis participants.
| Participant | Heparin Loading dose, units | Per hour dose, units | No. of hours | Total units of heparin received | Other anticoagulant | Dialysis Started | Approx. heparin dose at time of collection | Sample collected | APTTa (24–39 s) | PTa (9–13 s) |
|---|---|---|---|---|---|---|---|---|---|---|
| Dialysis 1 | 1000 | 1000 | 2 | 3000 | 0700 | 2000 | 0815 | 63.9 | 11.2 | |
| Dialysis 2 | Clexane 20 mg | 0700 | 0818 | 47.2 | 25.2 | |||||
| Dialysis 3 | 2000 | 1200 | 4 | 6800 | 0715 | 3200 | 0821 | 43.2 | 10.9 | |
| Dialysis 4 | 1500 | 500 | 3.5 | 3250 | 0715 | 2000 | 0825 | 27.1 | 12.1 | |
| Dialysis 5 | 2500 | 1500 | 5 | 10,000 | 0700 | 4000 | 0826 | 54.3 | 12.7 | |
| Dialysis 6 | 1000 | 500 | 3 | 4500 | Warfarin | 0800 | 2000 | 1010 | 53.4 | 42.2 |
| Dialysis 7 | 1000 | 1000 | 3 | 4000 | 0800 | 3000 | 1016 | 43.3 | 12.1 | |
| Dialysis 8 | 1000 | 1000 | 3 | 4000 | 0830 | 3000 | 1022 | 59.4 | 11.4 | |
| Dialysis 9 | 1000 | 500 | 2 | 2000 | 0745 | 2500 | 1028 | 43.9 | 11.8 | |
| Dialysis 10 | 1500 | 1000 | 4 | 5500 | Warfarin | 0845 | 3500 | 1030 | 35.4 | 17.1 |
aMeasured on ACL TOP 500 coagulation analyzers.
References
1. Clinical and Laboratory Standards Institute (CLSI). Procedures for the handling and processing of blood specimens for common laboratory tests; Approved Guideline, 4th ed. CLSI document H18-A4, 2010.Suche in Google Scholar
2. Dimeski G, Masci PP, Trabi M, Lavin MF, de Jersey J. Evaluation of the Becton-Dickinson rapid serum tube: does it provide a suitable alternative to lithium heparin plasma tubes? Clin Chem Lab Med 2010;48:651–7.10.1515/CCLM.2010.141Suche in Google Scholar
3. BD Vacutainer Rapid Serum Tube. Available at: https://www.bd.com/vacutainer/rst. Accessed May 30, 2016.Suche in Google Scholar
4. Koch CD, Wockenfus AM, Seanger AK, Jaffe AS, Karon BS. BD rapid serum tubes reduce false positive plasma troponin T results on the Roche Cobas e411 analyser. Clin Biochem 2012;45:842–4.10.1016/j.clinbiochem.2012.04.014Suche in Google Scholar
5. Strathmann FG, Ka MM, Rainey PM, Baird GS. Use of the BD vacutainer rapid serum tube reduces false-positive results for selected Beckman Coulter Unicel DxI immunoassays. Am J Clin Pathol 2011;136:325–9.10.1309/AJCPZOFJ7KX5QMRWSuche in Google Scholar
6. Lu’aulu SL, Straseski JA, Schmidt RL, Genzen JR. Thrombin-mediated degradation of parathyroid hormone in serum tubes. Clin Chim Acta 2014;437:191–196.10.1016/j.cca.2014.07.030Suche in Google Scholar
7. Yan R, Lou A, Watts G, Tarr H, Smith H, Kinney L, et al. Comparison of Becton Dickinson Vacutainer rapid serum tube with the serum separator tube for routine chemistry and immunoassay tests. J Clin Pathol 2014;67:599–604.10.1136/jclinpath-2013-202130Suche in Google Scholar
8. Pratt NL, Ramsey EN, Caughey GE, Shakib S, Roughead EE. Uptake of novel oral anticoagulants in Australia. Med J Aust 2016;204:104–6.10.5694/mja15.01000Suche in Google Scholar
9. Jones BA, Bekeris LG, Nakhleh RE, Walsh MK, Valenstein PN; College of American Pathologists. Physician satisfaction with clinical laboratory services: a College of American Pathologists Q-probes study of 138 institutions. Arch Pathol Lab Med 2009;133:38–43.10.5858/133.1.38Suche in Google Scholar
10. Dimeski G, Solano C, Petroff MK, Hynd M. Centrifugation protocols: tests to determine optimal lithium heparin and citrate plasma sample quality. Ann Clin Biochem 2011;48:218–22.10.1258/acb.2010.010230Suche in Google Scholar
11. Dubrowny NE, Harrop AJ. Collection device, US Patent No. 6686204, 2004.Suche in Google Scholar
12. Ryan JB, Stuart LA, Southby SJ, Than MP, Mackay R, Florkowski CM, et al. Comparison of BD Vacutainer® Rapid Serum Tube and plasma for haemolysis markers in the emergency department. Ann Clin Biochem 2015;52:293–6.10.1177/0004563214533317Suche in Google Scholar
13. Kreutzer HH, Fennis WHS. Lactic dehydrogenase isoenzymes in blood serum after storage at different temperatures. Clin Chim Acta 1964;9:64–8.10.1016/0009-8981(64)90045-2Suche in Google Scholar
14. Dimeski G, Coogan M, Jones B, Brown N. Is the new Beckman AccuTnI+3 assay capable of producing false-positive troponin I results? Clin Chem Lab Med 2015;53:e101–3.10.1515/cclm-2014-0616Suche in Google Scholar PubMed
15. National Pathology Laboratory Accreditation Advisory Council. Requirements for the retention of laboratory records and diagnostic material, 5th ed. 2009. Available at: http://www.health.gov.au/internet/main/publishing.nsf/Content/0392138A9970DFD1CA257371000D9200/$File/NPAAC%20Pub%20-%20Ret%20Records%20040110.pdf.Suche in Google Scholar
16. BD. Available at: https://www.bd.com/vacutainer/pdfs/VDP40152_rst_hemogard.pdf.Suche in Google Scholar
©2017 Walter de Gruyter GmbH, Berlin/Boston
Artikel in diesem Heft
- Frontmatter
- Editorial
- Biomarkers of acute kidney injury: a step forward
- Reviews
- Biomarkers of acute kidney injury: the pathway from discovery to clinical adoption
- Prognostic value of glycated hemoglobin among patients with ST-segment elevation myocardial infarction: a systematic review and meta-analysis
- Opinion Paper
- Traceability in laboratory medicine: a global driver for accurate results for patient care
- Point
- To report or not to report: a proposal on how to deal with altered test results in hemolytic samples
- Counterpoint
- Reporting altered test results in hemolyzed samples: is the cure worse than the disease?
- Genetics and Molecular Diagnostics
- Early mixed hematopoietic chimerism detection by digital droplet PCR in patients undergoing gender-mismatched hematopoietic stem cell transplantation
- Comparison of Abbott RealTime genotype II, GeneMatrix restriction fragment mass polymorphism and Sysmex HISCL HCV Gr assays for hepatitis C virus genotyping
- General Clinical Chemistry and Laboratory Medicine
- The relationship between vacuum and hemolysis during catheter blood collection: a retrospective analysis of six large cohorts
- Evaluation of the Greiner Bio-One serum separator BCA Fast Clot tube
- Implementation and application of moving average as continuous analytical quality control instrument demonstrated for 24 routine chemistry assays
- Parathormone stability in hemodialyzed patients and healthy subjects: comparison on non-centrifuged EDTA and serum samples with second- and third-generation assays
- Association between plasma proANP and hyperuricemia in Chinese Han women: a cross-sectional study
- Activity of the liver enzyme ornithine carbamoyltransferase (OTC) in blood: LC-MS/MS assay for non-invasive diagnosis of ornithine carbamoyltransferase deficiency
- Detecting paraprotein interference on a direct bilirubin assay by reviewing the photometric reaction data
- Prediction of human iron bioavailability using rapid c-ELISAs for human plasma hepcidin
- Reference Values and Biological Variations
- Determination of glucose-6-phosphate dehydrogenase cut-off values in a Tunisian population
- Plasma levels of endothelin-1 and renal function among young and healthy adults
- Cancer Diagnostics
- A new strategy for calculating the risk of ovarian malignancy algorithm (ROMA)
- Laboratory characterization of leukemic cell procoagulants
- Diabetes
- Preparation, calibration and evaluation of the First International Standard for human C-peptide
- Hb variants in Korea: effect on HbA1c using five routine methods
- Letters to the Editor
- Pseudohyperkalemia in capillary whole-blood samples – an occasional error or a significant problem in a pediatric hospital?
- Elevation of creatine kinase is linked to disease severity and predicts fatal outcomes in H7N9 infection
- Analytical evaluation of point-of-care procalcitonin (PCT) and clinical performances in an unselected population as compared with central lab PCT assay
- Evaluation of an automated commercial ELISA method for calprotectin determination in pleural fluid
- The unfinished story of interference in thyroid hormones with Roche immunoassays: when prewashing procedures matter
- Effects of apixaban on prothrombin time, activated partial thromboplastin time and anti-Xa assays: a European survey
- Evaluation of a chemiluminescent immunoassay for urinary aldosterone on the DiaSorin LIAISON automated platform against RIA and LC-MS/MS
- Complex considerations when tendering for HbA1c analysers
Artikel in diesem Heft
- Frontmatter
- Editorial
- Biomarkers of acute kidney injury: a step forward
- Reviews
- Biomarkers of acute kidney injury: the pathway from discovery to clinical adoption
- Prognostic value of glycated hemoglobin among patients with ST-segment elevation myocardial infarction: a systematic review and meta-analysis
- Opinion Paper
- Traceability in laboratory medicine: a global driver for accurate results for patient care
- Point
- To report or not to report: a proposal on how to deal with altered test results in hemolytic samples
- Counterpoint
- Reporting altered test results in hemolyzed samples: is the cure worse than the disease?
- Genetics and Molecular Diagnostics
- Early mixed hematopoietic chimerism detection by digital droplet PCR in patients undergoing gender-mismatched hematopoietic stem cell transplantation
- Comparison of Abbott RealTime genotype II, GeneMatrix restriction fragment mass polymorphism and Sysmex HISCL HCV Gr assays for hepatitis C virus genotyping
- General Clinical Chemistry and Laboratory Medicine
- The relationship between vacuum and hemolysis during catheter blood collection: a retrospective analysis of six large cohorts
- Evaluation of the Greiner Bio-One serum separator BCA Fast Clot tube
- Implementation and application of moving average as continuous analytical quality control instrument demonstrated for 24 routine chemistry assays
- Parathormone stability in hemodialyzed patients and healthy subjects: comparison on non-centrifuged EDTA and serum samples with second- and third-generation assays
- Association between plasma proANP and hyperuricemia in Chinese Han women: a cross-sectional study
- Activity of the liver enzyme ornithine carbamoyltransferase (OTC) in blood: LC-MS/MS assay for non-invasive diagnosis of ornithine carbamoyltransferase deficiency
- Detecting paraprotein interference on a direct bilirubin assay by reviewing the photometric reaction data
- Prediction of human iron bioavailability using rapid c-ELISAs for human plasma hepcidin
- Reference Values and Biological Variations
- Determination of glucose-6-phosphate dehydrogenase cut-off values in a Tunisian population
- Plasma levels of endothelin-1 and renal function among young and healthy adults
- Cancer Diagnostics
- A new strategy for calculating the risk of ovarian malignancy algorithm (ROMA)
- Laboratory characterization of leukemic cell procoagulants
- Diabetes
- Preparation, calibration and evaluation of the First International Standard for human C-peptide
- Hb variants in Korea: effect on HbA1c using five routine methods
- Letters to the Editor
- Pseudohyperkalemia in capillary whole-blood samples – an occasional error or a significant problem in a pediatric hospital?
- Elevation of creatine kinase is linked to disease severity and predicts fatal outcomes in H7N9 infection
- Analytical evaluation of point-of-care procalcitonin (PCT) and clinical performances in an unselected population as compared with central lab PCT assay
- Evaluation of an automated commercial ELISA method for calprotectin determination in pleural fluid
- The unfinished story of interference in thyroid hormones with Roche immunoassays: when prewashing procedures matter
- Effects of apixaban on prothrombin time, activated partial thromboplastin time and anti-Xa assays: a European survey
- Evaluation of a chemiluminescent immunoassay for urinary aldosterone on the DiaSorin LIAISON automated platform against RIA and LC-MS/MS
- Complex considerations when tendering for HbA1c analysers
